These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2539337

  • 1. Release of eicosanoids in rat peritoneal cavity during the Arthus reaction. Effect of the PAF-antagonist BN-52021 and indomethacin.
    Jancar S, Braquet P, Sirois P.
    Int J Immunopharmacol; 1989; 11(2):129-32. PubMed ID: 2539337
    [Abstract] [Full Text] [Related]

  • 2. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S, Braquet P, Sirois P.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218
    [Abstract] [Full Text] [Related]

  • 3. PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats.
    Rocha FA, Andrade LE, Russo M, Jancar S.
    J Lipid Mediat Cell Signal; 1997 May; 16(1):1-10. PubMed ID: 9101418
    [Abstract] [Full Text] [Related]

  • 4. Lipid mediator production in acute and chronic pancreatitis in the rat.
    Zhou W, Levine BA, Olson MS.
    J Surg Res; 1994 Jan; 56(1):37-44. PubMed ID: 8277767
    [Abstract] [Full Text] [Related]

  • 5. PAF induces rat plasma extravasation and releases eicosanoids during anaphylaxis.
    Jancar S, Sirois MG, Carrier J, Braquet P, Sirois P.
    Inflammation; 1991 Oct; 15(5):347-54. PubMed ID: 1757122
    [Abstract] [Full Text] [Related]

  • 6. Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions.
    Jancar S, Braquet P, Sirois P.
    Braz J Med Biol Res; 1987 Oct; 20(5):487-94. PubMed ID: 2838117
    [Abstract] [Full Text] [Related]

  • 7. Release of PAF-acether and eicosanoids from guinea-pig alveolar macrophages by FMLP: effect of cyclo-oxygenase and lipoxygenase inhibition.
    Fitzgerald MF, Parente L, Whittle BJ.
    Eur J Pharmacol; 1989 May 30; 164(3):539-46. PubMed ID: 2548873
    [Abstract] [Full Text] [Related]

  • 8. Paf-induced release of spasmogens from guinea-pig lungs.
    Jancar S, Thériault P, Lauzière M, Braquet P, Sirois P.
    Br J Pharmacol; 1989 Jan 30; 96(1):153-62. PubMed ID: 2538179
    [Abstract] [Full Text] [Related]

  • 9. Platelet-activating factor and eicosanoids are mediators of local and systemic changes induced by immune-complexes in mice.
    Steil AA, Teixeira CF, Jancar S.
    Prostaglandins Other Lipid Mediat; 1999 Jan 30; 57(1):35-48. PubMed ID: 10367295
    [Abstract] [Full Text] [Related]

  • 10. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
    Dembinska-Kiec A, Peskar BA, Muller MK, Peskar BM.
    Prostaglandins; 1989 Jan 30; 37(1):69-91. PubMed ID: 2717778
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
    Harczy M, Maclouf J, Pradelles P, Braquet P, Borgeat P, Sirois P.
    Pharmacol Res Commun; 1986 Aug 30; 18 Suppl():111-7. PubMed ID: 3095849
    [Abstract] [Full Text] [Related]

  • 12. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ, Stewart AG.
    Br J Pharmacol; 1987 Apr 30; 90(4):771-83. PubMed ID: 3034369
    [Abstract] [Full Text] [Related]

  • 13. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions.
    de Lima WT, Sirois P, Jancar S.
    Eur J Pharmacol; 1992 Mar 17; 213(1):63-70. PubMed ID: 1323472
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2 inhibits and indomethacin and aspirin enhance, A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages.
    Elliott GR, Lauwen AP, Bonta IL.
    Br J Pharmacol; 1989 Feb 17; 96(2):265-70. PubMed ID: 2538186
    [Abstract] [Full Text] [Related]

  • 15. Cyclic-AMP level and eicosanoid release from alveolar macrophages are differentially affected by high and low dose of platelet activating factor.
    Beusenberg FD, Bonta IL, van Amsterdam JG.
    Biochem Pharmacol; 1994 Feb 09; 47(3):588-90. PubMed ID: 8117329
    [Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor mediates trinitrobenzene induced colitis.
    Longo WE, Polities G, Vernava AM, Deshpande Y, Niehoff M, Chandel B, Kulkarni A, Kaminski DL.
    Prostaglandins Leukot Essent Fatty Acids; 1994 Dec 09; 51(6):419-24. PubMed ID: 7708808
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin E2, thromboxane B2, and leukotriene B4 release from peritoneal macrophages by different osmotic agents in nonuremic guinea pigs.
    Hain H, Jörres A, Kögel B, Mahiout A, Gahl GM, Kessel M.
    ASAIO Trans; 1988 Dec 09; 34(3):429-32. PubMed ID: 2848562
    [Abstract] [Full Text] [Related]

  • 18. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
    Hidi R, Coëffier E, Vargaftig BB.
    J Leukoc Biol; 1992 May 09; 51(5):425-31. PubMed ID: 1318347
    [Abstract] [Full Text] [Related]

  • 19. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
    Fletcher JR, DiSimone AG, Earnest MA.
    Ann Surg; 1990 Mar 09; 211(3):312-6. PubMed ID: 2178565
    [Abstract] [Full Text] [Related]

  • 20. In vivo rectal inflammatory mediator changes with radiotherapy to the pelvis.
    Cole AT, Slater K, Sokal M, Hawkey CJ.
    Gut; 1993 Sep 09; 34(9):1210-4. PubMed ID: 8406156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.